Focus Partners Wealth Takes Position in Oscar Health, Inc. (NYSE:OSCR)

Focus Partners Wealth bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 54,209 shares of the company's stock, valued at approximately $729,000.

Several other hedge funds and other institutional investors have also made changes to their positions in OSCR. JPMorgan Chase & Co. lifted its position in shares of Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after acquiring an additional 8,051,379 shares in the last quarter. BIT Capital GmbH lifted its position in shares of Oscar Health by 5,711.6% in the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after acquiring an additional 4,396,872 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its position in shares of Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after acquiring an additional 3,983,325 shares in the last quarter. Gilder Gagnon Howe & Co. LLC lifted its position in shares of Oscar Health by 51.4% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after acquiring an additional 2,151,256 shares in the last quarter. Finally, Clearbridge Investments LLC purchased a new position in shares of Oscar Health in the fourth quarter valued at approximately $19,088,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Insiders Place Their Bets

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the sale, the director now directly owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 24.39% of the stock is owned by insiders.

Oscar Health Stock Performance

Shares of Oscar Health stock opened at $17.52 on Monday. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The company has a market cap of $4.39 billion, a price-to-earnings ratio of -875.31 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The business's 50 day moving average price is $13.46 and its 200 day moving average price is $14.63.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. During the same quarter last year, the business posted $0.62 earnings per share. The firm's revenue was up 42.2% compared to the same quarter last year. On average, research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $20.08.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.